Kroeger, Knut, Kuepper-Nybelen, Jutta, Moerchel, Christian, Moysidis, Theodoros, Kienitz, Carsten and Schubert, Ingrid (2012). Prevalence and economic burden of pulmonary embolism in Germany. Vasc. Med., 17 (5). S. 303 - 310. LONDON: SAGE PUBLICATIONS LTD. ISSN 1358-863X

Full text not available from this repository.

Abstract

The prevalence of pulmonary embolism (PE), PE mortality and treatment-associated costs for the years 2000 to 2006 were analysed using a statutory health insurance sample of AOK Hesse/KV Hesse, which contained information for an 18.75% random sample of 1.9 million persons insured with the AOK Hesse. Within the sample a PE diagnosis was accepted as valid if it was documented as the main discharge diagnosis or as an additional hospital diagnosis during hospitalization and if at least one of the following criteria was met: prescription of oral anticoagulants or heparins, PE documented for at least two quarterly periods or documented in only one quarter for patients who died within 28 days after hospital discharge. The economic burden from the perspective of the insurance fund was assessed by an analysis of resource consumption (direct costs) and by a matched pair analysis with controls without PE to estimate excess costs. A 99% winsorization of each cost category was performed to control for extreme outlying values. The prevalence of PE as the main discharge diagnosis and an additional hospital diagnosis varied from 55.3 to 71.7 per 100,000 insurants in the years 2000 to 2006. Insurants aged 80 years and more had a prevalence of 406.9 per 100,000 (year 2006). From 2001 to 2003 the in-hospital mortality rate ranged from 20.4% to 24.9% and decreased to 14% in 2006. A total of 85% of all patients with PE who survived the first year had at least one prescription of vitamin K antagonists. For patients who survived the first year, treatment costs exceeded (sic) 20,000, with an estimation of additional costs of (sic) 5816 for men and (sic) 8962 for women in the matched-pair analysis. Owing to high in-hospital costs, the overall cost of treatment was highest for patients younger than 60 years. In conclusion, the prevalence rate of PE in Germany is comparable to international data. Treatment costs within the first year after hospital discharge are high, and there is a need to clarify the settings associated with PE in Germany with its high rate of prophylaxis.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Kroeger, KnutUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kuepper-Nybelen, JuttaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Moerchel, ChristianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Moysidis, TheodorosUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kienitz, CarstenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schubert, IngridUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-481803
DOI: 10.1177/1358863X12449363
Journal or Publication Title: Vasc. Med.
Volume: 17
Number: 5
Page Range: S. 303 - 310
Date: 2012
Publisher: SAGE PUBLICATIONS LTD
Place of Publication: LONDON
ISSN: 1358-863X
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; UNITED-STATES; HEALTH-INSURANCE; MORTALITY; CARE; PROPHYLAXIS; REPLACEMENT; REGISTRY; STROKEMultiple languages
Peripheral Vascular DiseaseMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/48180

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item